About Pyng
Pyng is a Healthcare company based in Richmond (Canada) founded in 1997, and was acquired by Teleflex Medical in February 2017. Sternal intraosseous pelvic stabilization devices for trauma. The company was acqui-hired. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies.
Company details
Pyng Medical provides military emergency response personnel with innovative sternal intraosseous pelvic stabilization devices. It has also started a product line of tourniquet devices with both civilian and military applications. The company has multiple patents to protect its products in US, Canada and Europe. T-PODResponder can be used on all patients with a suspected pelvic injury to stabilize the pelvis and prevent further movement and blood loss. FASTResponder is a sternal intraosseous device that delivers lifesaving fluids and medication to the heart and vascular system in less than one minute. MATResponder can be used to stop moderate to severe extremity blood loss from any limb, including a trapped limb, as a result of trauma to the limb. It has received several awards for its products including Gold 2000 Medical Design Excellence Award, Gold IDEA Award for Medical Product Design, 2008 Medical Device Company of the Year Award from LifeSciences British Columbia and Silver award from Industrial Designers Society of America.
- Headquarters Richmond, Canada
- Stage Public
- SectorsHealthcare
- Website pyng.com
- Social LinkedIn X
- Acquired by Teleflex Medical (Feb 2017)
- Latest Funding Round$105.58K (USD), Post-IPO
Nov 2015
- Investors
- Acquired byTeleflex Medical
(Feb 2017)
Funding Insights of Pyng
- Total Rounds 4
- Last Round Post-IPO β $105,582
- First Round $599,820
(Jan 2011)
All 4 funding rounds of Pyng with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2015 | $105,582 | Post-IPO | β | β | β |
| Oct 2013 | $588,118 | Post-IPO | β | β | β |
| Jun 2012 | $170,000 | Post-IPO | β | β | β |
| Jan 2011 | $599,820 | Post-IPO | β | β | β |
1 investors in total: 1 institutional.
Investors in Pyng
Pyng has secured backing from 1 investor. Prominent investors backing the company include Teleflex Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of medical devices for emergency medicine and various health conditions | 1943 | teleflex.com | Wayne, United States |
Investor details for Pyng
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pyng
5 dated milestones of Pyng across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Pyng is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $600K.
- Funding Latest funding round, Post-IPO, of $106K.
- Exit Acquired by Teleflex Medical.
Web traffic of Pyng
Websites that share an audience with Pyng (pyng.com).
Websites whose visitors overlap most with Pyng. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
matourniquet.com | matourniquet.com | 100% | β | ||
t-pod.com | t-pod.com | 99% | β | ||
| sterimeddisposables.com | 96% | 1.3K | #13,939,438 | View details | |
covision-medical.co.uk | covision-medical.co.uk | 96% | β | ||
| edwards.com | 96% | 202K | #223,603 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 9 similar websites and full traffic analytics for Pyng
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pyng
Pyng was founded in 1997 and raised its 1st funding round 14 years after it was founded.
Pyng is headquartered in Richmond, Canada. It is registered at Richmond, British Columbia, Canada.
Pyng Medical provides military emergency response personnel with innovative sternal intraosseous pelvic stabilization devices. It has also started a product line of tourniquet devices with both civilian and military applications. The company has multiple patents to protect its products in US, Canada and Europe. T-PODResponder can be used on all patients with a suspected pelvic injury to stabilize the pelvis and prevent further movement and blood loss. FASTResponder is a sternal intraosseous device that delivers lifesaving fluids and medication to the heart and vascular system in less than one minute. MATResponder can be used to stop moderate to severe extremity blood loss from any limb, including a trapped limb, as a result of trauma to the limb. It has received several awards for its products including Gold 2000 Medical Design Excellence Award, Gold IDEA Award for Medical Product Design, 2008 Medical Device Company of the Year Award from LifeSciences British Columbia and Silver award from Industrial Designers Society of America.
Pyng has 1 investor. Key investors include Teleflex Medical.
Yes. Pyng was acquired by Teleflex Medical in February 2017.
